Evaluating seizures associated with novel antineoplastic agents during breast cancer treatment using the Food and Drug Administration Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database
This dual-database pharmacovigilance study identifies potential associations between seizures and five novel BC therapies, underscoring the need for vigilant monitoring during their clinical use.
Authors
- Yi Du (ORCID: https://orcid.org/0000-0001-9568-0907)
- Jiguang Han (ORCID: https://orcid.org/0000-0002-5973-2842)
- Xiaoshuan Liang
- Yan Sha (ORCID: https://orcid.org/0000-0002-4596-8432)
- Shanshan Sun (ORCID: https://orcid.org/0000-0002-9175-083X)
- Xiaoming Li (ORCID: https://orcid.org/0000-0003-1795-0371)
- Yu Lu (ORCID: https://orcid.org/0009-0003-8520-4722)
- Quan Yuan
- Yao Qian
- Ming Niu
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Therapeutic Advances in Drug Safety
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1177/20420986251405091
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31